Please login or register first to view this content.
Immune Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
January 2023 Recap: Drug Pipeline Updates
Belimumab Granted Orphan Drug Status for Systemic Sclerosis
Avapritinib Gets Priority Review for Indolent Systemic Mastocytosis
FDA Approves Room Temp Storage Conditions for Asceniv and Bivigam
September 2022 Recap: Drug Pipeline Updates
Leniolisib Gets Priority Review for Activated Phosphoinositide 3-Kinase Delta Syndrome
Continuation of Anti-TNF for IBD After 24 Weeks of Pregnancy Beneficial
Reduction in Swollen, Tender Joints Greater With Litifilimab in Lupus
August 2022 Recap: Drug Pipeline Update
Imbruvica Approved for Pediatric Patients With Chronic Graft-vs-Host Disease
Deoxycytidine Kinase Inhibitor Designated Orphan Drug for Optic Neuritis
Benlysta Approval Expanded to Include Pediatric Lupus Nephritis
Risk for Guillain-Barré Syndrome Up After Ad.26.COV2.S Vaccination
Efzofitimod Granted Orphan Drug Status for Systemic Sclerosis
FDA Extends Shelf Life of Immune Globulin Products Asceniv and Bivigam
Jergens Moisturizer Recalled Due to Bacteria Risk
Certain Immune Globulin Products Withdrawn Due to Higher Rate of Hypersensitivity Reactions
Lilly Ends Baricitinib Lupus Program, Provides Update on Atopic Dermatitis sNDA